PIA
ARKG icon

Powell Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Powell Investment Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Buy
+3,962
New +$126K 0.05% 132
2025
Q3 		– Sell
-820
Closed -$20K – 167
2025
Q2 		$20K Buy
+820
New +$18K 0.01% 162

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Powell Investment Advisors's ARKG Position: Q2 2026 in Review

Powell Investment Advisors opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 3,962 shares worth $167K. The stake represents 0.05% of the portfolio and ranks #132 among its holdings. This is a return to the name: Powell Investment Advisors previously reported a position in ARKG as recently as Q2 2025.

Powell Investment Advisors first reported a position in ARKG in Q2 2025 and has held it in 2 quarters since. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Powell Investment Advisors held 3,962 shares of ARK Genomic Revolution ETF worth $167K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Powell Investment Advisors position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.05% of Powell Investment Advisors's portfolio in Q2 2026, its #132 holding.
  • Powell Investment Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2025 and has held it in 2 quarters since.
  • 274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Powell Investment Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.